EP 1395827 A2 20040310 - USE OF CYTOSOLIC NADP-DEPENDENT ISOCITRATE DEHYDROGENASE IN BODILY FLUIDS AND STOOLS FOR IDENTIFYING A MALIGN ILLNESS
Title (en)
USE OF CYTOSOLIC NADP-DEPENDENT ISOCITRATE DEHYDROGENASE IN BODILY FLUIDS AND STOOLS FOR IDENTIFYING A MALIGN ILLNESS
Title (de)
VERWENDUNG VON CYTOSOLISCHER NADP-ABHÄNGIGER ISOCITRAT-DEHYDROGENASE IN KÖRPERFLÜSSIGKEITEN UND STUHL ZUM NACHWEIS EINER MALIGNEN ERKRANKUNG
Title (fr)
UTILISATION D'ISOCITRATE-DESHYDROGENASE CYTOSOLIQUE NADP-DEPENDANTE DANS DES FLUIDES CORPORELS ET DES SELLES, POUR DETECTER UNE MALADIE MALIGNE
Publication
Application
Priority
- DE 0202020 W 20020601
- DE 10126763 A 20010601
- DE 10126762 A 20010601
Abstract (en)
[origin: WO02099431A2] The invention relates to a method for identifying a malign illness in humans or animals and to a test kit for carrying out the inventive method. The invention also relates to the use of said test kit for the selective identification of cytosolic NADP-dependent isocitrate dehydrogenase in human or animal bodily fluids and stools and for the determination of the extent of the malign illness and of a system of treatment.
IPC 1-7
IPC 8 full level
G01N 33/573 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
G01N 33/573 (2013.01); G01N 33/574 (2013.01); G01N 2333/904 (2013.01); G01N 2333/91215 (2013.01)
Citation (search report)
See references of WO 02099431A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02099431 A2 20021212; WO 02099431 A3 20030220; DE 10292477 D2 20040429; EP 1395827 A2 20040310
DOCDB simple family (application)
DE 0202020 W 20020601; DE 10292477 T 20020601; EP 02745117 A 20020601